Reprogramming somatic cells into a pluripotent state involves the overexpression of transcription factors leading to a series of changes that end in the formation of induced pluripotent stem cells (iPSCs). These iPSCs have a wide range of potential uses from drug testing and in vitro disease modelling to personalized cell therapies for patients. While viral methods for reprogramming factor delivery have been traditionally preferred due to their high efficiency, it is now possible to generate iPSCs using nonviral methods at similar efficiencies. We developed a robust reprogramming strategy that combines episomal plasmids and the use of commercially available animal free reagents that can be easily adapted for the GMP manufacture of clinical grade cells.
CITATION STYLE
Caxaria, S., Arthold, S., Nathwani, A. C., & Goh, P. A. (2014). Generation of integration-free patient specific ips cells using episomal plasmids under feeder free conditions. In Methods in Molecular Biology (Vol. 1353, pp. 355–366). Humana Press Inc. https://doi.org/10.1007/7651_2015_204
Mendeley helps you to discover research relevant for your work.